| Nfkbib |
Mus musculus |
|
Nfkbib is differentially expressed in 92 experiments [86 up/94 dn]: 40 organism parts: liver [3 up/5 dn], kidney [0 up/4 dn], ...; 4 disease states: synovial sarcoma [0 up/1 dn], normal [1 up/0 dn], ...; 26 cell types, 1 cell lines, 9 compound treatments and 9 other conditions. |
| Ikbb, Nfkbib, mCG_2994 |
|
IKBB_RAT (Rattus norvegicus)
cact (Drosophila melanogaster)
NFKBIB (Homo sapiens)
(Compare orthologs)
|
|
|
| Ankyrin repeat, Ankyrin repeat-containing domain, Nuclear Factor kappaB inhibitor |
|
|
| cytoplasmic sequestering of NF-kappaB, cytosol, nucleus, protein binding |
|
|
|
Q564F1
Q60778
Q80WN0
Q8VC27
Q80WN1
|
|
|
|
ENSMUSG00000030595
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Liver
|
Organism part |
|
|
Wild_type
|
Genotype |
|
|
Control
|
Compound treatment |
|
|
Kidney
|
Organism part |
|
|
Testis
|
Organism part |
|
|
Hippocampus
|
Organism part |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
Hypothalamus
|
Organism part |
|
|
Embryonic stem cell
|
Cell type |
|
|
Amygdala
|
Organism part |
|
|
C57BL/6J
|
Strain or line |
|
|
Colon
|
Organism part |
|
|
Uninfected
|
Infection |
|
|
Ovary
|
Organism part |
|
|
E15.5
|
Developmental stage |
|
|
None
|
Compound treatment |
|
|
Hematopoietic stem cell
|
Cell type |
|
|
P23
|
Developmental stage |
|
|
Somatic cell
|
Cell type |
|
|
Adult
|
Developmental stage |
|
|
Embryo
|
Developmental stage |
|
|
Skeletal muscle
|
Organism part |
|
|
E13.5
|
Developmental stage |
|
|
Pituitary gland
|
Organism part |
|
|
Partial hepatectomy
|
Injury |
|
|
Jejunum
|
Organism part |
|
|
CBA/CaJ
|
Strain or line |
|
|
Control
|
Infection |
|
|
Mycobacterium tuberculosis
|
Infection |
|
|
Ileum
|
Organism part |
|
|
Periaqueductal grey
|
Organism part |
|
|
Spermatogonium
|
Cell type |
|
|
Spermatid
|
Cell type |
|
|
Th1
|
Cell type |
|
|
Th2
|
Cell type |
|
|
Sertoli cell
|
Cell type |
|
|
Heart
|
Organism part |
|
|
Macrophage
|
Cell type |
|
|
Thymocyte
|
Cell type |
|
|
Pam3CSK4
|
Compound treatment |
|
|
ATF3(-/-)
|
Genotype |
|
|
Thyroid
|
Organism part |
|
|
Superior colliculus
|
Organism part |
|
|
Cingulate cortex
|
Organism part |
|
|
CREM(-/-)
|
Genotype |
|
|
Blastocyst
|
Developmental stage |
|
|
Soleus muscle
|
Organism part |
|
|
Medial gastrocnemius
|
Organism part |
|
|
Yersinia enterocolitica WA(pTT...
|
Infection |
|
|
Tristetrapolin-deficient
|
Genotype |
|
|
2-cell
|
Developmental stage |
|
|
P14
|
Developmental stage |
|
|
Bmal1-/-
|
Genotype |
|
|
Neural stem/progenitor cell
|
Cell type |
|
|
Yersinia enterocolitica WA(pYV...
|
Infection |
|
|
MYD88(-/-)
|
Genotype |
|
|
Oocyte
|
Developmental stage |
|
|
Trans-10, cis-12 conjugated li...
|
Compound treatment |
|
|
Poly I:C
|
Compound treatment |
|
|
Empty vector
|
Gene modification |
|
|
T regulatory cell
|
Cell type |
|
|
GABAergic interneuron
|
Cell type |
|
|
P16
|
Developmental stage |
|
|
E18
|
Developmental stage |
|
|
Pachytene spermatocyte
|
Cell type |
|
|
Neural
|
Observation |
|
|
Non-neural
|
Observation |
|
|
Atrial chamber
|
Organism part |
|
|
C/EBP delta
|
Gene modification |
|
|
Lacrimal gland
|
Organism part |
|
|
E12
|
Developmental stage |
|
|
E8.5
|
Developmental stage |
|
|
1-cell
|
Developmental stage |
|
|
Mesenteric LN_CD4+CD25-
|
Cell type |
|
|
Not cultured
|
Growth condition |
|
|
Cultured
|
Growth condition |
|
|
Retina
|
Organism part |
|
|
C/EBP alpha
|
Gene modification |
|
|
Synovial sarcoma
|
Disease state |
|
|
Normal
|
Disease state |
|
|
Lung
|
Organism part |
|
|
Glycogen synthase -/-
|
Genotype |
|
|
Cycloheximide (pretreatment)+ ...
|
Compound treatment |
|
|
Extraocular muscle
|
Organism part |
|
|
Gastrocnemius muscle
|
Organism part |
|
|
8-cell
|
Developmental stage |
|
|
C/EBP epsilon
|
Gene modification |
|
|
Pkd1 -/-
|
Genotype |
|
|
Muscle
|
Organism part |
|
|
Bone marrow
|
Organism part |
|
|
Spermatocyte
|
Cell type |
|
|
Microglial cell
|
Cell type |
|
|
Hippocampus CA17
|
Organism part |
|
|
SCD1-/-
|
Genotype |
|
|
Tcf1-/-
|
Genotype |
|
|
Periaqueductal gray
|
Organism part |
|
|
Anterior tibialis
|
Organism part |
|
|
GSL30
|
Genotype |
|
|
Cerebral cortex
|
Organism part |
|
|
Human chorionic gonadotrophin
|
Compound treatment |
|
|
Hippocampus CA1
|
Organism part |
|
|
T-reg_control-treated
|
Cell type |
|
|
GABAergic neuron
|
Cell type |
|
|
P28
|
Developmental stage |
|
|
SCA1 model
|
Genotype |
|
|
CD45-
|
Cell type |
|
|
CD45+
|
Cell type |
|
|
Submandibular gland
|
Organism part |
|
|
Bed nucleus stria terminalis
|
Organism part |
|
|
Peripheral LN_CD4+CD25+
|
Cell type |
|
|
White adipose tissue
|
Organism part |
|
|
Natural killer
|
Cell type |
|
|
B117P
|
Cell line |
|
|
NLS20 line X50
|
Strain or line |
|
|
Bed nucleus of the stria termi...
|
Organism part |
|
|
Dentate gyrus
|
Organism part |
|
|
Pancreatic islet
|
Organism part |
|
|
129S6/SvEvTac
|
Strain or line |
|
|
Resting bulk splenocytes
|
Cell type |
|
|
SCA1 knock-in
|
Genotype |
|
|
Trypanosoma congolense
|
Infection |
|
|
Gata-1(-/-)
|
Genotype |
|
|
TICAM1(-/-)
|
Genotype |
|
|
Normal oxygen
|
Growth condition |
|
|
100% oxygen
|
Growth condition |
|
|
Oocyte
|
Organism part |
|
|
B220+ B cell
|
Cell type |
|
|
Multiple myeloma tumour cell
|
Cell type |
|
|
Monoclonal gammopathy of undet...
|
Disease state |
|
|
Multiple myeloma
|
Disease state |
|
|
Mammary gland
|
Organism part |
|
|
Control
|
Clinical treatment |
|
|
Dinitrofluorobenzene
|
Compound treatment |
|
|
|
|
|
Processing time: 0.126 secs.